Integer Holdings Corporation (NYSE:ITGR - Get Free Report)'s stock price reached a new 52-week low on Tuesday . The company traded as low as $99.73 and last traded at $100.11, with a volume of 654541 shares traded. The stock had previously closed at $101.34.
Wall Street Analyst Weigh In
Several brokerages have recently weighed in on ITGR. Truist Financial cut their price objective on shares of Integer from $145.00 to $137.00 and set a "buy" rating on the stock in a report on Friday, July 25th. Wall Street Zen raised Integer from a "hold" rating to a "buy" rating in a research note on Saturday, August 30th. Raymond James Financial cut their target price on Integer from $150.00 to $143.00 and set an "outperform" rating for the company in a research note on Friday, July 25th. Finally, Wells Fargo & Company reduced their target price on Integer from $152.00 to $132.00 and set an "overweight" rating on the stock in a report on Friday, July 25th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock has an average rating of "Buy" and an average price target of $140.25.
Get Our Latest Stock Analysis on ITGR
Integer Stock Performance
The firm's 50-day moving average is $107.85 and its two-hundred day moving average is $115.28. The company has a current ratio of 3.41, a quick ratio of 2.18 and a debt-to-equity ratio of 0.72. The stock has a market cap of $3.62 billion, a price-to-earnings ratio of 45.47, a P/E/G ratio of 0.82 and a beta of 1.03.
Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.02). The company had revenue of $476.00 million for the quarter, compared to analyst estimates of $464.37 million. Integer had a return on equity of 12.27% and a net margin of 4.61%.Integer's revenue was up 11.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.30 earnings per share. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. As a group, sell-side analysts expect that Integer Holdings Corporation will post 6.01 earnings per share for the current year.
Institutional Trading of Integer
Large investors have recently modified their holdings of the company. State Street Corp grew its position in Integer by 1.0% in the 2nd quarter. State Street Corp now owns 1,326,050 shares of the medical equipment provider's stock valued at $163,064,000 after buying an additional 13,540 shares in the last quarter. Viking Global Investors LP lifted its position in shares of Integer by 9.1% in the second quarter. Viking Global Investors LP now owns 1,283,965 shares of the medical equipment provider's stock worth $157,889,000 after purchasing an additional 106,692 shares in the last quarter. Alliancebernstein L.P. raised its position in Integer by 885.1% during the second quarter. Alliancebernstein L.P. now owns 1,106,091 shares of the medical equipment provider's stock valued at $136,016,000 after acquiring an additional 993,810 shares in the last quarter. Franklin Resources Inc. raised its position in Integer by 11.5% during the second quarter. Franklin Resources Inc. now owns 907,232 shares of the medical equipment provider's stock valued at $111,562,000 after acquiring an additional 93,294 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in Integer by 3.9% during the second quarter. Geode Capital Management LLC now owns 819,089 shares of the medical equipment provider's stock valued at $100,736,000 after acquiring an additional 31,026 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company's stock.
Integer Company Profile
(
Get Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Further Reading
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.